EPND-12. TYROSINE KINASE INHIBITORS AXITINIB, IMATINIB AND PAZOPANIB ARE SELECTIVELY POTENT IN EPENDYMOMA

Reproducibly effective chemotherapy has yet to be identified for ependymoma (EPN), partly due to a lack of models for preclinical drug screening. Treatment of EPN has therefore changed little over the last 40 years and is essentially limited to surgery and radiation. Recurrence risk is high, particu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Donson, Andrew, Werner, Elliot, Amani, Vladimir, Griesinger, Andrea, Witt, Davis, Nellan, Anandani, Vibhakar, Rajeev, Hankinson, Todd, Handler, Michael, Dorris, Kathleen, Foreman, Nicholas
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2017
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475033/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.070
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg